Stand­ing on the Shoul­ders of a Tiny Gi­ant

by Brooke An­der­son

Don't you won­der how a sin­gle species can range from pro­tec­tive gut com­men­sal to lethal pa­tho­gen to lab­o­ra­tory best-friend, and yet still be Es­cherichia coli ? With such broad va­ri­ety, how si­mi­lar can all these strains be? True, their con­served genes have a 98% se­quence sim­i­lar­ity, but other genes vary by up to 40% be­tween the lab strain and path­o­genic strains.1 Even mem­bers of the same serotypes vary greatly. In fact, the Shigella species, which since prac­ti­cally day one of mi­cro­bi­o­lo­gy have been deemed wor­thy of their own genus, map phy­lo­ge­net­i­cally within the wide bound­aries of E. coli .2

Fig­ure. En­tero­tox­i­genic E. coli  (ETEC) ex­press­ing CFA/I pili. Bac­terium is ~1 µM x 3 µM, pili are he­li­cal fil­a­ments ~8 nm in di­am­e­ter and over 1 µM long. Source

With worlds of mi­cro­bi­ol­ogy still un­ex­plored, E. coli  may seem like a bland and rather ex­hausted topic. Yet I have been mus­ing whether our do­mes­ti­cated lab strains of E. coli  are ac­tu­ally good mod­els for gram neg­a­tive bac­te­ria in na­ture. Of course E. coli  to­day is fre­quently used to sim­ply stock ge­netic ma­te­r­ial, but there are also many labs that use it to in­ves­ti­gate ba­sic prokary­otic phys­i­ol­ogy and be­hav­ior. Is this jus­ti­fied?

E. coli  is an old friend in the lab, and was so even be­fore tractable toolk­its were es­tab­lished to make ge­netic ma­ni­pu­lation so much eas­ier. What was it about E. coli  a cen­tury ago that prompted the sci­en­tific com­mu­nity to adopt it so com­pletely as the prokary­otic model?

E. coli 's his­tory be­gins in 1886 when the bac­terium was dis­cov­ered by Theodor Es­cherich. In­spired by the germ the­ory of dis­ease and the then-cur­rent work of Louis Pas­teur and Robert Koch, the Ger­man-Aus­trian pe­di­a­tri­cian col­lected fe­ces of his young pa­tients. From in­fants with di­ar­rhea, he iso­lated a fast-grow­ing, rod-shaped mi­crobe that he named 'Bac­terium coli com­mune'. Fol­low­ing his death in 1919, this bac­terium was re­named af­ter him Es­cherichia coli . Ac­cord­ing to Joshua Leder­berg, a 1958 No­bel Prize win­ner for dis­co­ver­ing bac­te­r­ial con­ju­ga­tion, E. coli  was used by re­searchers from the very start for the rea­sons most model species are fa­vored: it grew fast on var­i­ous me­dia, it was eas­ily iso­lated and iden­ti­fied on me­dia such as MacConkey's agar, and many strains were harm­less.

The par­ent of our mod­ern lab strain E. coli  MG1655 is the K‑12 strain, iso­lated in 1922 from the stool of a diph­the­ria pa­tient and stored in Stan­ford stocks (as of the late 1990s the orig­i­nal strain was still main­tained in stab cul­tures).3 Berk­men and Riggs pre­vi­ously pre­sented the story of this strain on these pages here in STC. In the 1930's, Charles Clifton at Stan­ford used the stock cul­ture to study the growth char­ac­ter­is­tics of E. coli , pre­sum­ably be­cause of how sim­ple it is to grow in liq­uid cul­ture, but also be­cause "of the more ex­ten­sive in­for­ma­tion avail­able on its me­tab­o­lism and the ease with which con­t­a­m­i­nants may be de­tected."4 This echoes Lederberg's as­sess­ment that early on re­searchers val­ued E. coli 's rapid growth, in­nocu­ous na­ture, and ease of iden­ti­fi­ca­tion.

From Clifton, the K‑12 strain moved into the hands of Ed­ward L. Tatum for early bio­chem­i­cal stu­dies. Fol­low­ing Av­ery, MacLeod, and McCarty's ev­i­dence that DNA was the hered­i­tary ma­te­r­ial in strains of pneu­mo­cocci, Joshua Leder­berg, then work­ing in E. L. Tatum's lab, be­gan to work on es­tab­lish­ing ge­netic tools for his then-fa­vored fun­gus, Neu­rospora. He ap­par­ently ran into enough prob­lems in cre­at­ing mu­tants in this species that he be­gan to look for a bet­ter can­di­date.5 When he was given Tatum's K‑12 strain, he read­ily cre­ated aux­otrophic mu­tants that, when mixed to­gether, elim­i­nated each other's aux­otro­phies and pro­vided the first ev­i­dence of a prokaryote's abil­ity to sex­u­ally trans­fer genes.6

It turns out that most wild strains of E. coli  do not con­ju­gate. So how did Tatum & Leder­berg ma­nage to stum­ble upon one of the few strains that did? Ac­cord­ing to Bar­bara Bach­mann, a widely re­garded E. coli  his­to­rian, "that this vir­ile strain of E. coli, one of the rel­a­tively few found to pos­sess sig­nif­i­cant fer­til­ity in the lab­o­ra­tory, should have been the one which C. E. Clifton chose to give to E. L. Tatum as the lat­ter set out to pro­duce mu­tant strains of bac­te­ria was ap­par­ently just a par­tic­u­larly happy ac­ci­dent. K‑12 was thought to be an en­tirely typ­i­cal coli cul­ture."7 From here on out what Leder­berg dubbed the bi­o­log­i­cal "Matthew ef­fect" (in ref­er­ence to a line in the Gospel of Matthew which es­sen­tially posits that the rich get richer and the poor get poorer) took hold: E. coli  K‑12, with the rich­est col­lec­tion of knowl­edge and tools, con­tin­ued to ac­cu­mu­late more strain-cen­tric find­ings as it was pas­saged out in labs across the globe.8 Bac­te­rio­phage re­search be­came cen­tered on E. coli  and its lambda phage. Arthur Ko­rn­berg used it to make his sem­i­nal con­tri­bu­tion of DNA repli­ca­tion in 1956.

In the 50 years since the ac­cre­tion of ge­netic tools for E. coli , the K‑12 strain has gen­er­ated an ex­ten­ded pedi­gree. In 1972 Bar­bara Bach­mann be­gan to col­lect and arrange a large col­lec­tion of strains from an im­pres­sive foray through the records of sev­eral labs. The MG1655 com­monly used to­day de­rived from Lederberg's K‑12 col­lec­tion, where it was cured of the lambda phage by UV light and of the F plas­mid by acri­dine or­ange so that it could no longer per­form con­ju­ga­tion.7 The MG1655 strain (named by Mark Guyer) is con­sid­ered to be the clos­est to the orig­i­nal K‑12 strain, mi­nus these two lost genes, mu­ta­tions in the ilvG and rfb genes, un­cer­tainty about the "true" wild-type al­lele of the rpoS gene, and a frameshift mu­ta­tion in the rph gene en­cod­ing RNase PH.9

So it seems rea­son­able to con­clude that E. coli  be­came the most stud­ied prokary­ote, de­lib­er­ately or not, for the ex­act rea­sons that most mod­els arise: it grows fast and cheaply; can be iso­lated and iden­ti­fied by sim­ple meth­ods; it won't harm the re­searchers; and a good amount of lit­er­a­ture on it ex­isted. So, what can E. coli  still tell us about prokary­otes in na­ture?

Ob­vi­ously, no sin­gle or­gan­ism is rep­re­sen­ta­tive of oth­ers even of its own species, much less be­yond that. This is true even for a lab­o­ra­tory strain that has been pas­saged un­der lab­o­ra­tory con­di­tions for decades be­cause it ac­cu­mu­lates mu­ta­tions to best suit it grow­ing in the lab on me­dia it's fed. Richard Lenski showed that af­ter 33,000 gen­er­a­tions over fif­teen years, E. coli  REL606 evolved the abil­ity to aer­o­bi­cally uti­lize cit­rate as a car­bon source, which it has never been able to do in the past.10 A sim­i­lar ex­per­i­ment tested which genes could pro­vide a fit­ness ad­van­tage when in­ac­ti­va­ted and pas­saged in liq­uid cul­ture for 60 – 90 gen­er­a­tions. The lost genes that were found to pro­vide a fit­ness ad­van­tage were fla­gel­lar genes, which aid in mo­bil­ity and biofilm for­ma­tion but are en­ergy ex­pen­sive.11

This is an ex­am­ple of where study­ing some­thing so bi­o­log­i­cally fun­da­men­tal as fla­gel­lar struc­ture could be un­der­mined by the do­mes­ti­ca­tion of the strain. Com­par­ing geno­types of strains, both lab do­mes­ti­cated and iso­lated from the wild, has been and will con­tinue to be aided by the ease of se­quencing prokary­otic genomes. How­ever, I would also un­der­line the im­por­tance of un­der­stand­ing and con­sid­er­ing the me­dia used to prop­a­gate strains. For E. coli  strains iso­lated from the wild, es­pecially when in­volved in health stud­ies such as food safety, stud­ies might ben­e­fit from a syn­thetic medium cus­tomized to the sub­strates and con­di­tions typ­i­cal of the en­vi­ron­ment where they were found.

For an added layer of com­plex­ity, mod­ern mi­cro­bi­ol­o­gists are now hy­per-aware of the mi­cro­bial bio­mes that ex­ist every­where, mod­u­lat­ing the ac­tiv­ity of their con­stituents. The nat­ural en­vi­ron­ments in which wild strains are found al­ways in­clude other mi­cro­bial life. Garth Ehrlich and col­leagues note that "the biofilm pro­vides an ideal set­ting for bac­te­r­ial hor­i­zon­tal gene trans­fer."12 They thus pro­poses "The Dis­trib­uted Genome Hy­poth­e­sis," which looks through the whole po­pu­la­tion to ac­cu­mu­late a species-genome, there­fore ac­count­ing for in­stances of hor­i­zon­tal gene trans­fer. This al­lows re­searchers to zoom out from the lone, un­rep­re­sen­ta­tive strain of E. coli  to ex­am­ine the ca­pa­bil­i­ties of all mem­bers of a species. With this new per­spec­tive of study­ing mi­crobes such as E. coli  in the con­text of their en­vi­ron­men­tal neigh­bors, we can start to un­der­stand how and why E. coli  genomes have di­verged to such ex­tremes, both in labs and in na­ture.

 

Ref­er­ences

  1. Welch RA, Bur­land V, Plun­kett G 3rd, Red­ford P, Roesch P, Rasko D, Buck­les EL, Liou SR, Boutin A, Hack­ett J, Stroud D, May­hew GF, Rose DJ, Zhou S, Schwartz DC, Perna NT, Mob­ley HL, Don­nen­berg MS, Blat­tner FR. 2002. Ex­ten­sive mo­saic struc­ture re­vealed by the com­plete genome se­quence of uropath­o­genic Es­cherichia coli. Proc Natl Acad Sci U S A, 99 (26), 17020 – 17024 PMID 12471157
  2. Tou­chon M, Hoede C, Tenail­lon O, Barbe V, Baeriswyl S, Bidet P, Bin­gen E, Bona­corsi S, Bouch­ier C, Bou­vet O, Cal­teau A, Chi­a­pello H, Cler­mont O, Cru­veiller S, Danchin A, Di­ard M, Dos­sat C, Karoui ME, Frapy E, Garry L, Ghigo JM, Gilles AM, John­son J, Le Bouguénec C, Lescat M, Mangenot S, Mar­tinez-Jéhanne V, Matic I, Nas­sif X, Oz­tas S, Pe­tit MA, Pi­chon C, Rouy Z, Ruf CS, Schnei­der D, Tour­ret J, Vacherie B, Val­lenet D, Médigue C, Rocha EP, De­na­mur E. 2009. Or­gan­ised genome dy­nam­ics in the Es­cherichia coli species re­sults in highly di­verse adap­tive paths. PLoS Genet, 5 (1), e1000344 PMID 19165319
  3. Bach­mann, BJ. 1996. De­riva­tions and Geno­types of Some Mu­tant De­riv­a­tives of Es­cherichia coli K‑12. in: Es­cherichia coli and Sal­mo­nella, 2nd Ed. p 2460 – 2488. ASM Press (out of print) ISBN-13: 978–1555810849 (textbooks.com)
  4. Cleary JP, Beard PJ, Clifton CE. 1935. Stud­ies of Cer­tain Fac­tors In­flu­enc­ing the Size of Bac­te­r­ial Pop­u­la­tions. J Bac­te­riol, 29  (2), 205 – 213 (1935). PMID 16559778
  5. John­ston, M. et al. Joshua Leder­berg on Bac­te­r­ial Re­com­bi­na­tion. Ge­net­ics 203, 613 – 614 (2016). http://www.ncbi.nlm.nih.gov/pubmed/27270693
  6. Tatum, E. L. & Leder­berg, J. Gene Re­com­bi­na­tion in the Bac­terium Es­cherichia coli. J. Bac­te­riol. 53, 673 – 684 (1947). http://www.ncbi.nlm.nih.gov/pubmed/16561324
  7. Bach­mann, B. J. Pedi­grees of some mu­tant strains of Es­cherichia coli K‑12. Bac­te­riol. Rev. 36, 525–57 (1972). http://www.ncbi.nlm.nih.gov/pubmed/4568763
  8. Leder­berg J. 2004. E. coli K‑12. Mi­cro­bi­ol­ogy To­day 31, 116.
  9. Hayashi K, Mo­rooka N, Ya­mamoto Y, Fu­jita K, Isono K, Choi S, Oht­subo E, Baba T, Wan­ner BL, Mori H, Ho­ri­uchi T. 2006. Highly ac­cu­rate genome se­quences of Es­cherichia coli K‑12 strains MG1655 and W3110. Mol Syst Biol, 2, 2006.0007 PMID 16738553
  10. Blount ZD, Bar­rick JE, David­son CJ, Lenski RE. 2012. Ge­nomic analy­sis of a key in­no­va­tion in an ex­per­i­men­tal Es­cherichia coli pop­u­la­tion. Na­ture, 489 (7417), 513 – 518 PMID 22992527
  11. Ed­wards RJ, Sock­ett RE, Brook­field JF. 2002. A sim­ple method for genome-wide screen­ing for ad­van­ta­geous in­ser­tions of mo­bile DNAs in Es­cherichia coli. Curr Biol, 12 (10), 863 – 867 PMID 12015126
  12. Ehrlich GD, Ahmed A, Earl J, Hiller NL, Coster­ton JW, Stood­ley P, Post JC, De­Meo P, Hu FZ. 2010. The dis­trib­uted genome hy­poth­e­sis as a rubric for un­der­stand­ing evo­lu­tion in situ dur­ing chronic bac­te­r­ial biofilm in­fec­tious processes. FEMS Im­munol Med Mi­cro­biol, 59 (3), 269 – 279 PMID 20618850

 

Brooke Anderson

Brooke An­der­son is a grad­u­ate stu­dent in the lab of Rachel Dut­ton at UC San Diego. She en­joys bask­ing in her luck to work with the tasti­est of mi­crobiological sub­jects, cheese.

 

Other Posts